Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Nov 2;113(11):1523-1530.
doi: 10.1093/jnci/djab083.

Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial

Affiliations
Randomized Controlled Trial

Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial

Jolyn Hersch et al. J Natl Cancer Inst. .

Abstract

Background: Supporting well-informed decisions about breast cancer screening requires communicating that inconsequential disease may be detected, leading to overdiagnosis and overtreatment. Having previously shown that telling women about overdetection improved informed choice, we investigated effects on screening knowledge and participation over 2 years.

Methods: We conducted a community-based, parallel-group, randomized controlled trial in Australia. Participants were women aged 48-50 years, without personal or strong family history of breast cancer, who had not undergone mammography in the past 2 years. We randomly assigned 879 women to receive the intervention decision aid (evidence-based information on overdetection, breast cancer mortality reduction, and false-positives) or control decision aid (identical but without overdetection information). We interviewed 838 women postintervention and recontacted them for follow-up at 6 months and 1 and 2 years. Main outcomes for this report are screening knowledge and participation.

Results: We interviewed 790, 746, and 712 participants at 6 months, 1, and 2 years, respectively. The intervention group demonstrated superior knowledge throughout follow-up. After 2 years, conceptual knowledge was adequate in 123 (34.4%) of 358 women in the intervention group compared with 71 (20.1%) of 354 control participants(odds ratio = 2.04, 95% confidence interval = 1.46 to 2.85). Groups were similar in total screening participation (200 [55.1%] vs 204 [56.0%]; = 0.97, 95% confidence interval = 0.73 to 1.29).

Conclusions: A brief decision aid produced lasting improvement in women's understanding of potential consequences of screening, including overdetection, without changing participation rates. These findings support the use of decision aids for breast cancer screening.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Trial profile extended to include long-term follow-up. Further details about recruitment and procedures prior to randomization have been published (22).
Figure 2.
Figure 2.
Key self-reported outcomes. For all outcomes shown, the group x time interaction is statistically significant (P < .05). Con = control group; Int = intervention group.

Comment in

References

    1. Brawley OW, Paller CJ.. Overdiagnosis in the age of digital cancer screening. J Natl Cancer Inst. 2021;113(1):1–2. - PMC - PubMed
    1. de Ligt KM, Heins M, Verloop J. , et al. Patient-reported health problems and healthcare use after treatment for early-stage breast cancer. Breast. 2019;46:4–11. - PubMed
    1. Smith BD, Jiang J, Shih YC. , et al. Cost and complications of local therapies for early-stage breast cancer. J Natl Cancer Inst. 2017;109(1):djw178. - PMC - PubMed
    1. Taylor C, Correa C, Duane FK. , et al.; for the Early Breast Cancer Trialists’ Collaborative Group. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–1649. - PMC - PubMed
    1. Mehta LS, Watson KE, Barac A. , et al. Cardiovascular disease and breast cancer: where these entities intersect. Circulation. 2018;137(8):e30-66. - PMC - PubMed

Publication types